Polypharmacy is a concern for older adults, with some studies suggesting that obesity may be a contributing factor. The condition is associated with a higher risk of mortality and hospitalizations, and may be particularly burdensome for certain groups, such as those with liver disease. The exact relationship between obesity and polypharmacy is still being explored, but it is estimated that obesity may account for a significant proportion of polypharmacy cases.